title: Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group.
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: D A
authors.initials: DA
authors.lastname: Eichenauer
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Goergen
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Plütschow
authors.affiliation: German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Wongso
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Behringer
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Kreissl
authors.affiliation: German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Thielen
authors.affiliation: German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Halbsguth
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: P J
authors.initials: PJ
authors.lastname: Bröckelmann
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Fuchs
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Böll
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: B
authors.initials: B
authors.lastname: von Tresckow
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Borchmann
authors.affiliation: Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.|German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Engert
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005858:Germany; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016879:Salvage Therapy; D015996:Survival Rate; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C527517:ofatumumab